Sritama Bose is the Associate Director of Chemistry at Orfonyx Bio, a biotech spun out of the University of Oxford, where she leads multiple projects developing nucleic acid therapeutics.
Before joining Orfonyx, she served as Head of Chemistry Research & Innovation at the Medical Research Council’s Nucleic Acid Therapy Accelerator (UKRI). Sritama earned her PhD in synthetic organic chemistry from the Indian Association for the Cultivation of Science, specializing in the total synthesis of bioactive natural products.
Her diverse international postdoctoral experiences include research at Peking University, Stellenbosch University, and the Slovak Academy of Sciences. She further specialized in nucleic acid chemistry as a Postdoctoral Research Associate at Durham University, UK.
With a strong drive for translational research, Sritama transitioned to Sygnature Discovery, a UK drug discovery CRO. As a Senior Scientist, she applied her organic synthesis expertise to drug development, gaining valuable medicinal chemistry insights that she now brings to her leadership role at Orfonyx Bio.